The Chart of the Day belongs to the healthcare company AptarGroup (ATR) I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 7/14 the stock gained 6.94%.
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
Barchart Technical Indicators:
- 100% technical buy signals
- 25.00+ Weighted Alpha
- 17.04% gain in the last year
- Trend Seeker buy signal
- Above its 20, 50 and 100 day moving averages
- 4 new highs and up 5.79% in the last month
- Relative Strength Index 72.77%
- Technical support level at $125.79
- Recently traded at $127.59 with 50 day moving average of $119.01
Fundamental Factors:
- Market Cap 8.21 billion
- P/E 30.47
- Dividend yield 1.33%
- Revenue expected to grow by 5.50% this year and another 4.80% next year
- Earnings estimated to increase 20.30% this year, an additional 9.00% next year and continue to compound at an annual rate of 7.00% for the next 5 years
Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:
- Wall Street analyst gave 2 strong buy, 1 buy, and 3 hold opinions on the stock
- Analysts have a price target of $125 to $150 with a consensus of $137
- The individual investors following the stock on Motley Fool voted 82 to 5 for the stock to beat the market with the more experienced investors voting 23 to 2 for the same result
- Value Line gives the stock its average rating of 3
- CFRA's MarketScope rates it a 4 star strong buy with a price target of $138
- 2,840 investors monitor the stock on Seeking Alpha
Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in the next 72 hours.
Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance and reevaluate your stop losses at least on a weekly basis.
On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
